Sacituzumab tirumotecan improved survival for patients with EGFR TKI–resistant, EGFR‐mutant advanced NSCLC

Cancer 2026 Open access

Read full text

Authors: Leah Lawrence

DOI: 10.1002/cncr.70250

Cited by: 1

References: 5

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Colorectal Cancer Treatments and Studies Melanoma and MAPK Pathways

References 5